bioRxivNeurosciencePreprint
Disrupted Transcriptional Networks by Mutant Atrophin-1 in a Cell Culture Model of Dentatorubral-Pallidoluysian Atrophy
Oluwademilade NugaiD, Masoumeh PourhadiiD, Julia P. Rausch, Sokol V. TodiiD
Abstract
Dentatorubral-Pallidoluysian Atrophy (DRPLA) is a dominant neurodegenerative disease caused by CAG triplet repeat expansion in ATN1, which encodes the transcriptional co-repressor Atrophin-1. DRPLA features motor, cognitive, and epileptic symptoms and shares pathogenic mechanisms with other polyglutamine (polyQ) disorders, including protein misfolding, impaired autophagy, and transcriptional dysregulation. To understand disease mechanisms, we performed RNA-seq on HEK293T cells stably expressing wild-type or polyQ-expanded ATN1. Cells expressing pathogenic ATN1 exhibited a distinct transcriptomic profile, including disruptions in synaptic organization, extracellular matrix remodeling, ion channel expression, and neurotransmission. Several genes tied to neurodevelopmental, neurodegenerative, and oncogenic pathways were fully activated or silenced. Dysregulated pathways also included inflammation, chromatin remodeling, stress responses, and redox imbalance. Heat shock protein expression changes suggested proteotoxic stress and impaired protein quality control, with some findings conserved in a previously reported Drosophila melanogaster model of DRPLA. These transcriptomic signatures expand our understanding of molecular events related to degeneration in DRPLA and may lead to the identification of therapeutic targets.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Insights into Dentatorubral-Pallidoluysian Atrophy from a new Drosophila model of disease
Matthew V. Prifti, Oluwademilade Nuga, … Sokol V. Todi·Neurobiology of DiseasePeer-reviewed·Feb 5, 2025
- Atrophin-1 Antisense Oligonucleotide Provides Robust Protection from Pathology in a Fully Humanized DRPLA Model
Velvet L. Smith, Bereket Z. Gidi, … Jeffrey B. Carroll·Molecular Therapy — Nucleic AcidsPeer-reviewed·Dec 31, 2025
- Mitochondrial dysfunction precedes neurodegeneration in DRPLA patient-derived neurons, and phenylbutyrate improves survival.
Njoud Al-Naama, Csaba Konràd, … Margaret Elizabeth Ross·bioRxiv·Sep 2, 2025
- A Humanized Mouse Model of DRPLA Recapitulates Epilepsy and Demonstrates Antisense Oligonucleotide-Mediated Disease Modification
Qian Wu, Inga Erickson, … Melissa L. Barker‐Haliski·bioRxiv·Oct 18, 2026
- Transcriptome analysis in a humanized mouse model of familial dysautonomia reveals tissue-specific gene expression disruption in the peripheral nervous system.
Ricardo Harripaul, Elisabetta Morini, … Susan Slaugenhaupt·Scientific ReportsPeer-reviewed·Jan 4, 2024
- Ataxin-2 polyglutamine expansions aberrantly sequester TDP-43, drive ribonucleoprotein condensate transport dysfunction and suppress local translation
D. Wijegunawardana, S. S. Vishal, … P. P. Gopal·bioRxiv·Jan 30, 2023